Grass P - Search Results

1

Discovery of proteins related to coronary artery disease using industrial-scale proteomics analysis of pooled plasma.

Donahue MP, Rose K, Hochstrasser D, Vonderscher J, Grass P, Chibout SD, Nelson CL, Sinnaeve P, Goldschmidt-Clermont PJ, Granger CB. Donahue MP, et al. Among authors: grass p. Am Heart J. 2006 Sep;152(3):478-85. doi: 10.1016/j.ahj.2006.03.007. Am Heart J. 2006. PMID: 16923417

2

Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease.

Sinnaeve PR, Donahue MP, Grass P, Seo D, Vonderscher J, Chibout SD, Kraus WE, Sketch M Jr, Nelson C, Ginsburg GS, Goldschmidt-Clermont PJ, Granger CB. Sinnaeve PR, et al. Among authors: grass p. PLoS One. 2009 Sep 14;4(9):e7037. doi: 10.1371/journal.pone.0007037. PLoS One. 2009. PMID: 19750006 Free PMC article.

3

Population pharmacodynamic analysis of octreotide in acromegalic patients.

Comets E, Mentré F, Grass P, Kawai R, Marbach P, Vonderscher J. Comets E, et al. Among authors: grass p. Clin Pharmacol Ther. 2003 Jan;73(1):95-106. doi: 10.1067/mcp.2003.6. Clin Pharmacol Ther. 2003. PMID: 12545148

4

Effects of clofibric acid on mRNA expression profiles in primary cultures of rat, mouse and human hepatocytes.

Richert L, Lamboley C, Viollon-Abadie C, Grass P, Hartmann N, Laurent S, Heyd B, Mantion G, Chibout SD, Staedtler F. Richert L, et al. Among authors: grass p. Toxicol Appl Pharmacol. 2003 Sep 1;191(2):130-46. doi: 10.1016/s0041-008x(03)00231-x. Toxicol Appl Pharmacol. 2003. PMID: 12946649

5

Sandostatin LAR (microencapsulated octreotide acetate) in acromegaly: pharmacokinetic and pharmacodynamic relationships.

Grass P, Marbach P, Bruns C, Lancranjan I. Grass P, et al. Metabolism. 1996 Aug;45(8 Suppl 1):27-30. doi: 10.1016/s0026-0495(96)90075-x. Metabolism. 1996. PMID: 8769375 Clinical Trial.

6

Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patients.

Lancranjan I, Bruns C, Grass P, Jaquet P, Jervell J, Kendall-Taylor P, Lamberts SW, Marbach P, Orskov H, Pagani G, Sheppard M, Simionescu L. Lancranjan I, et al. Among authors: grass p. Metabolism. 1996 Aug;45(8 Suppl 1):67-71. doi: 10.1016/s0026-0495(96)90087-6. Metabolism. 1996. PMID: 8769387 Clinical Trial.

7

Short-term continuous infusion of octreotide in acromegaly. Pharmacokinetics and prediction of the response to long-term treatment.

Timsit J, Chanson P, Harris AG, Grass P, Guillausseau PJ, Warnet A, Lubetzki J. Timsit J, et al. Among authors: grass p. Horm Metab Res. 1991 Jan;23(1):48-9. doi: 10.1055/s-2007-1003610. Horm Metab Res. 1991. PMID: 2016081 No abstract available.

8

A comparison of octreotide, bromocriptine, or a combination of both drugs in acromegaly.

Fløgstad AK, Halse J, Grass P, Abisch E, Djøseland O, Kutz K, Bodd E, Jervell J. Fløgstad AK, et al. Among authors: grass p. J Clin Endocrinol Metab. 1994 Aug;79(2):461-5. doi: 10.1210/jcem.79.2.8045964. J Clin Endocrinol Metab. 1994. PMID: 8045964

9

Pharmacokinetics and haemodynamic effects of a single oral dose of the novel ACE inhibitor spirapril in patients with chronic liver disease.

Krähenbühl S, Grass P, Surve A, Kutz K, Reichen J. Krähenbühl S, et al. Among authors: grass p. Eur J Clin Pharmacol. 1993;45(3):247-53. doi: 10.1007/BF00315391. Eur J Clin Pharmacol. 1993. PMID: 8276049 Clinical Trial.

10

Spirapril: pharmacokinetic properties and drug interactions.

Grass P, Gerbeau C, Kutz K. Grass P, et al. Blood Press Suppl. 1994;2:7-13. Blood Press Suppl. 1994. PMID: 8061850

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters